United Kingdom· GB-APID-10639111000001104
CeeNU 10mg capsules
A lomustine product containing lomustine, registered in United Kingdom by Imported (United States). The same ATC class is registered in 10 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Lomustine is registered in 10 of 19 countries.
Countries holding a registration under ATC L01AD02 (lomustine), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 4 of them publish a price we can compare per daily dose
Lomustine · ATC L01AD02
10 / 19 countries
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Netherlands
- Norwayprice
- Sweden
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Lomustine
- Manufacturer
- Imported (United States)
- Country
- United Kingdom (GB)
- ATC code
- L01AD02
- ATC class
- Lomustine
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
166 interactions on record for lomustine.
Graded by severity as the source publishes them — 36 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lomustine · interactions on record
166 records
- 36 severe
- 112 moderate
- 18 minor
Most severe, free to view
- CimetidineA02BA01severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- Nalidixic acidJ01MB02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Lomustine in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayCeenuBristol-Myers Squibb
- CanadaCEENUBRISTOL-MYERS SQUIBB CANADA
- United StatesLOMUSTINECarnegie Pharmaceuticals LLC
- NetherlandsLomustine BModesto capsules, hard 40 mgBModesto B.V.
- SwedenLomustine Medac 40 mg Kapsel, hårdmedac Gesellschaft für klinische Spezialpräparate mbH
- SpainBELUSTINE CAPSULASBellon
- GermanyCecenu®Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)
- FinlandLomustine medacMedac Gesellschaft Für Klinische Spezialpräparate mbH
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Austria · Lomustin (Ccnu) Medac
- Germany · Cecenu®
- Denmark · Lomustine Medac
- Finland · Lomustine Medac
- France · Lomustine Medac
- Sweden · Lomustine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/962cb877-94d2-4385-9736-bfbf0606b283 GET /v1/drugs/962cb877-94d2-4385-9736-bfbf0606b283?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "10639111000001104",
"desc": "CeeNU 10mg capsules (Imported (United States))",
"form": "Oral capsule",
"vpid": "41790911000001100",
"source": "dmd",
"vtm_id": "776565006",
"strength": "10 mg",
"substance": "Lomustine",
"ingredient": "Lomustine",
"supplier_code": "11821411000001108"
}See everything about lomustine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.